Disclaimer: Opinions posted on Free Republic are those of the individual posters and do not necessarily represent the opinion of Free Republic or its management. All materials posted herein are protected by copyright law and the exemption for fair use of copyrighted works.
THE BLOOD BROKERS; Fourth in a series
When the American Association of the Red Cross was formed by Clara
Barton
on May 21, 1881, it was with a clear mission.
As owner of Chapin Medical Co. in Anaheim, Calif., Mark Johnson
does
considerable business with the American Red Cross.
For one thing, his company serves as a national distributor of Red
Cross
plasma medicines, delivering them to hospitals wherever the Red Cross
has
contracts. Chapin Medical and a number of other national distributors
are
paid a fee for these services.
But Johnson also buys plasma medicines from the Red Cross
outright,
marks them up and sells them to hospitals on his own.
"If I call up a hospital that has no relationship with Red Cross,
then
I'll sell at any price I can get," Johnson said. "It's a
substantial
business to us."
In other words, the Red Cross, a nonprofit organization that gets
its
blood free from donors, sells some of the medicines it makes to
Johnson's
for-profit company for resale.
That is one example of the Red Cross' involvement in the
commercial
plasma business, in which it earned an estimated $75 million last year.
The
Red Cross has about a 15 percent share of the plasma market.
In this market, the Red Cross competes head-to-head with
for-profit
companies - but pays no state or federal taxes on this business.
Competitors argue it should.
Commercial plasma companies say that the Red Cross has an
unfair
business advantage - that its blood operations have become so
extensive
that those revenues are no longer substantially related to the
charitable
mission for which the tax exemption was originally granted.
"I'm all for competition, but it has to be on a level playing field.
To
the extent that Red Cross has this incredible advantage of not
paying
taxes, it is unfair," said Jack J. Luchese, former vice president of
Armour
Pharmaceutical Co. in Blue Bell, Pa., one of the largest makers of
plasma
medicines in the United States.
Red Cross officials defend their tax-exempt status by citing
the
charitable nature of their work and the fact that profits remain within
the
organization and are not distributed to shareholders.
As for the Red Cross' aggressive entry into the plasma
business,
officials assert that they are acting as a "steward" of the plasma that
is
part of the blood collected by the Red Cross from unpaid donors.
Dr. Lewellys F. Barker, Red Cross senior vice president for
blood
services, acknowledged in testimony before a U. S. House subcommittee
in
1987 that the lines between the Red Cross and for-profit companies
have
blurred. But he rejected the idea that the Red Cross should pay taxes.
"A great strength of the American system is that it has room for
private
enterprise and for the nonprofit provision of human services," he
said.
"Sometimes, the lines between these functions become blurred.
This,
however, seems a small price to pay for the opportunity for
private
citizens to organize to help their neighbors without constant recourse
to
government."
H. Edward Matveld, vice president of Alpha Therapeutic
Corp., a
commercial manufacturer of plasma products based in Los Angeles,
offered a
different view during the 1987 hearings, which looked into the question
of
whether charitable organizations should be taxed on certain of
their
operations.
Matveld estimated that the Red Cross earned $51 in net profit on
every
liter of plasma it processed into medicines - compared with $11 a
liter
earned by for-profit companies.
"The results, therefore, allow (the Red Cross) to
substantially
influence the market price," Matveld said.
The oversight subcommittee of the House Ways and Means Committee
is
still looking into the activities of nonprofit organizations.
In 1978, the Internal Revenue Service was asked for an advisory
opinion
on whether the income from the sale of plasma by a tax-exempt blood bank
to
a commercial firm was taxable. Such IRS opinions are called
revenue
rulings.
The IRS said the issue turned on whether the trade or business
was
"substantially related" to the exempt purposes of the organization.
When
tax-exempt blood banks sell plasma that is the byproduct of their
routine
blood collections (plasma separated from whole blood they have
collected),
the revenue should be considered exempt from taxation - since
blood
collection is an exempt purpose, the IRS said.
However, when blood banks purchase plasma from other blood centers
to
resell, or begin to collect plasma by a separate procedure known
as
plasmapheresis (in which a donor gives blood, the plasma is separated
out
from the whole blood and the red cells are recycled back into the
donor),
then they are involved in "unrelated trade" and the income from those
sales
is taxable, the IRS ruled.
The IRS has not been asked to rule on whether nonprofit blood
banks
retain their tax-exempt status when they sell plasma medicines
to
for-profit companies, as in the case of Chapin Medical.
"We pay (taxes) where we have been asked (by the IRS)," Barker
said.
"But I don't believe this is an area. . . . There are few areas where
we
do."
Barker could think of only two businesses on which the Red Cross
reports
taxable income: revenue from parking lots it operates and income
from
office space it leases.
A Red Cross spokesperson, Pat Davis, said: "We have a very
limited
amount of unrelated income. It is mostly property and rental
income.
However, after applying the allowable deductions against the income,
there
is no tax liability."
At least three other large nonprofit blood organizations have
started
paying taxes on their plasma businesses in recent years. In each
instance,
the organization formed a separate for-profit corporation, which it uses
to
buy and sell plasma.
The three are Blood Systems Inc. of Scottsdale, Ariz.; Gulf
Coast
Regional Blood Center of Houston, and Blood Centers of America
Inc., a
corporation based in Providence, R. I., that was created by eight
nonprofit
blood centers.
"What we want to avoid is someone saying: 'You guys have an
unfair
competitive advantage because you don't pay taxes,' " said Bill T.
Teague,
president and chief executive officer of Gulf Coast.
"We want to keep things clear so there is absolutely no problem with
the
IRS," Teague said. He has good reason to be concerned: "The IRS has
audited
us on an average every three years," he said.
Barker said most of the Red Cross' plasma business involved
the
distribution of medicines to hospitals. In some cases, these products
are
sold directly to the hospitals by the Red Cross' 56 blood centers. In
other
cases, they are distributed by companies such as Chapin Medical.
In addition, distributors such as Chapin buy medicines directly from
the
Red Cross. Barker said he could not say how much blood the Red Cross
sells
to for-profit firms but said the amount was small.
Is selling plasma medicines to commercial companies in keeping with
the
Red Cross' nonprofit mission?
"Well, we do have a board of governors' policy for disposition of
excess
materials," Barker said. "That is to say, we really have two choices
in
some situations. One is to destroy them and the other is to turn them
over
to an entity that has a need for them and try to get compensated."
Johnson, however, said the medicines he buys from the Red Cross are
no
different from the medicines the Red Cross sells to hospitals.
"It's all the same," he said. "Look, there's a minimum of three to
five
years' (effectiveness) and it's always sold within three to five years."
Johnson would not say how much he buys from the Red Cross, only that
it
was a "substantial" part of his $25 million business. He said he buys
both
from national headquarters and regional blood centers.
The bulk of the Red Cross' plasma is manufactured under contract by
the
Hyland Division of Baxter Healthcare Inc., a $6 billion
diversified
corporation. Hyland, in Glendale, Calif., processes about 900,000 of
the
1.1 million liters of plasma collected by the Red Cross each
year,
according to documents and interviews.
Hyland is paid a fixed fee for each processed liter, based on the
number
and mix of plasma medicines, estimated at $25 a liter, or about
$22.5
million annually.
In 1986, the Red Cross-Baxter relationship was expanded when they
signed
a contract under which the Red Cross agreed to purchase all the
plastic
blood-collection bags it uses from Fenwal Labs Inc., another subsidiary
of
Baxter Healthcare. According to the Red Cross' 1987 tax return, it
also
paid Fenwal $2.3 million for "consulting/research & development."
A company that suffered as a result of the agreement was
Cutter
Biologicals Inc., one of the largest manufacturers of plasma
derivatives
and maker of one brand of the plastic bags used to collect blood.
"As a result of that (agreement) . . . the Red Cross use of blood
bags
became closed to us in one fell swoop," said Cutter attorney and
spokesman
R. J. Modersbach.
Modersbach said the Red Cross accounts for half of the estimated
$80
million U. S. market for blood bags.
The Los Angeles Red Cross center was one of those that had to switch.
"We didn't like it," said administrator Norman R. Kear. "We already
had
a good supplier - Cutter."
PHOTO (1), 1. Mark Johnson, president of Chapin Medical Co., buys
plasma
medicines from the Red Cross and resells them. (The Philadelphia
Inquirer /
J. KYLE KEENER)
The Red Cross is not all blood and guts.
While blood services and disaster relief together account for nearly
70
percent of expenditures, the American Red Cross also sponsors a variety
of
community activities.
Last year, of its $978 million total expenditures, about 10 percent
went
to management and fund raising. About 20 percent - or $196 million -
was
used to provide services to members of the armed forces and thousands
of
communities scattered throughout the United States.
Some Red Cross community and health programs are well-known.
For
example, last year, the Red Cross trained more than 2.5 million people
in
Cardiopulmonary Resuscitation (CPR) and instructed more than two
million
others in lifesaving and water-safety techniques. Fees are charged
for
these services.
As part of its health programs, the Red Cross screened 1.3
million
persons for high blood pressure and 156,215 persons for cholesterol
levels
in their blood.
More than one million active members of the military benefited from
Red
Cross services - services ranging from helping to locate family members
to
arranging for benefits, according to the Red Cross' annual report.
Workers
also helped 135,276 veterans, the report says.
Red Cross chapters - there are 2,817 - also offer hundreds
of
lesser-known services.
In the Philadelphia area, the Southeastern Pennsylvania chapter of
Red
Cross offers a weeklong leadership training program for students at
Ursinus
College, where they learn a broad range of skills.
In Fort Wayne, Ind., the Red Cross chapter trains persons to baby
sit
infants at risk for SIDS (Sudden Infant Death Syndrome).
In Milwaukee, the Red Cross chapter rents car-safety seats for
infants
and small children.
In Fairfield, Conn., the Red Cross chapter teaches children
safety
techniques for times when they are alone in their homes.
And in Milton, Fla., the Red Cross chapter maintains a referral list
of
persons who will provide respite relief for families with handicapped
and
bedridden members.
Other safety courses provided by Red Cross chapters include
outboard
boating, canoeing, sailing and kayaking. In addition, there are programs
on
alcoholism, parenting, good grooming and home care for people with
multiple
sclerosis.
A charter later approved by Congress spelled out its purpose
as a
voluntary relief agency providing medical aid to victims of wars and
other
great "national calamities," including pestilence, famine, fire and
floods.
That is still the image the Red Cross portrays in its advertising
and
solicitations. "When people are in trouble, the American Red Cross
gets
down to business - the emergency-services business. It's what we do
best,"
the Red Cross said in its 1986 annual report.
But tax records and financial statements show that, a century after
its
founding, the Red Cross' main business is no longer disaster relief.
Its main business is selling blood.
Consider these facts:
* Fifty-nine cents out of every dollar that the Red Cross spent in
the
fiscal year ended June 30, 1988, went to operate its blood program.
Less
than a dime out of every dollar went to disaster services.
* The majority of the Red Cross' revenues - nearly 53 percent -
now
comes from blood, up from 19 percent in 1971.
* From 1980 through 1987, the blood program generated average
operating
profits of $38 million a year. Last year, profits fell to $4 million
as a
result of safety problems that increased costs. The blood program's
total
profits, which the Red Cross calls "excesses over expenses," were
nearly
$307 million for the 1980-88 period.
* From 1980 through 1988, the blood program's net worth grew
161
percent, to $188 million. Overall, the Red Cross had a net worth of
nearly
$1 billion in 1988, with cash and investments of $559 million listed on
its
balance sheets. (Net worth is the amount by which an organization's
assets
exceed its liabilities.)
In short, the Red Cross has undergone a major transformation in the
last
15 years - from predominantly a relief agency to a giant in the
blood
business.
Today, the Red Cross controls at least half of all the blood
collected
and sold to hospitals in the United States.
The Red Cross' blood operations are so big that if the blood
program
alone were a public company, its 1988 revenues of $535.5 million would
have
ranked 477th on the Fortune 500, just ahead of Affiliated
Publications
Inc., owner of the Boston Globe.
And the Red Cross' total 1988 revenues of $985 million from all
sources
would have ranked 339th on the Fortune 500, ahead of Bausch & Lomb
Inc.,
the lens and eye-care company.
Before its financial problems last year, the Red Cross' profit
margin
would have been the envy of many companies. Its overall 8.7 percent
profit
margin in 1987, for instance, would have ranked 98th on the Fortune
500,
ahead of such giants as General Electric Co., Mobil Corp. and
Chrysler
Corp.
Another advantage those corporations could only wish for: the
services
of nearly 1.4 million volunteers, who donate their time for Red Cross
blood
drives, First Aid classes and disaster aid. That's in addition to
the
organization's 23,357 paid workers.
Over the years, the Red Cross has built a vast network that now
includes
56 regional blood centers, a Washington headquarters, 2,817 Red
Cross
chapters, a multimillion-dollar research lab, a closed-circuit
television
network and production studio, and its own offshore insurance
company
Boardman Indemnity Ltd. in Bermuda - to cover losses from AIDS lawsuits
and
other claims.
And as a nonprofit charitable organization, the Red Cross benefits
from
$90 million worth of free television, radio and print advertising a
year,
at least one-third of which is devoted to its blood program.
In recent years the Red Cross has become a major player in the
largely
commercial plasma business, where the Red Cross now has about a 15
percent
share of the U. S. market, with sales of about $75 million a year.
The Red Cross' rise to dominance of the blood business has not
been
without controversy. Officials of other nonprofit blood banks criticize
it
for aggressive tactics and say the Red Cross is trying to take over
the
blood business. And its commercial competitors contend that the Red
Cross
has an unfair competitive advantage because of its tax-exempt status,
which
they say the blood portion of its operations does not deserve.
"Red Cross is in business - both in the blood business and in
the
finished plasma business - and building up a Taj Mahal," said Thomas
Hecht,
chairman of Continental Pharma Cryosan Inc., a plasma business in
Montreal.
"The American Red Cross is perceived by the public as a benevolent
group
of volunteers, who make the donation of blood as painless and
socially
significant as possible," H. Edward Matveld of Alpha Therapeutics
Inc.,
said in testimony in June 1987 before a U. S. House subcommittee that
was
examining the question of taxing nonprofit groups. "The public is
not
generally aware of . . . its incredible wealth.
" . . . The plasma services division (of the Red Cross) has
grown
disproportionately so that its revenues are not substantially related
to
the performance of the original tax-exempt purpose," Matveld said.
"It
therefore appears appropriate for Congress to review the American Red
Cross
charter and mission as they pertain to competitive, for-profit
activities."
Red Cross officials have fended off suggestions the organization
should
pay taxes on its blood business, arguing that no one benefits
personally
from its profits, which are used to further the organization's work.
Red
Cross officials also say they act as stewards of the blood they
collect
from unpaid donors.
"We have no stockholders," Dr. Lewellys F. Barker, the Red Cross'
senior
vice president for blood services, said in an interview. "To me,
that's
probably the most fundamental difference between nonprofit and
commercial
entities. We both need to have substantial finances to be able to
provide
our services.
"Our objective is to meet patients' needs," Barker said. "I think
it's
pretty traditional in this country for business objectives to
make a
profit. I don't object to that. That's their primary purpose, as I see
it.
But that's not our primary purpose."
In earlier testimony before the congressional subcommittee
examining
nonprofits, Barker said: "We operate (the blood services)
on a
cost-recovery basis. That is to say, obviously, the total revenue with
an
excess that we require for working capital and equipment and buildings
and
so forth basically balances the total expenses. It is a wash."
Its critics contend that the Red Cross has used its "excesses" -
profits
- over the years to build an ever-expanding empire, paying
executive
salaries of $150,000 or more and amassing larger-than-necessary
financial
reserves.
In the interview with The Inquirer, Barker was asked about a 15
percent
profit margin budgeted for the Red Cross' plasma business this year.
He
said that the Red Cross needs to maintain adequate reserves. "This
is a
service which has some cycles, ups and downs, for which we need
(financial)
reserves."
It is Red Cross policy that each of its 56 blood centers should
maintain
financial reserves sufficient to cover a minimum of 45 days' worth
of
operations, and up to a maximum of 180 days. However, an internal Red
Cross
financial document obtained by The Inquirer notes that "some regions
have
liquidity levels above what can reasonably be considered necessary
to
operate their blood centers.
"In a few cases, liquidity levels exceed one year. As a
nonprofit
organization, it is difficult for the Red Cross to explain the need
for
excessive amounts of liquidity," the Feb. 17, 1989, internal report
said.
While the blood business has been a major revenue source for the
Red
Cross, profits from blood are not used to pay for disaster relief. The
two
programs are operated separately.
The blood program is self-supporting; other Red Cross services, such
as
disaster relief and water-safety programs, are financed
through
contributions from the public - $315 million in 1988. Most of
those
contributions come through the United Way.
One reason the Red Cross is sensitive about its profits from blood
sales
is fear that public knowledge about them might affect
charitable
contributions, some industry officials say.
"Red Cross doesn't want the American public to know it is a big
blood
business," said James Holland, former president of Blood Centers of
America
Inc., which represents eight nonprofit blood banks. Holland said that
the
Red Cross promotes its disaster-relief activities and plays down its
blood
program "to keep the (charitable) donations coming in."
In Philadelphia, the Southeastern Pennsylvania Chapter of Red
Cross
received 52 percent - or $3,173,506 - of its funding in 1988 from
United
Way contributions. The chapter had total revenues of $6.1 million last
year
and spent $885,036 on disaster services. Its largest expenditures
were
nearly $1.6 million contributed to national headquarters in Washington
and
$1.1 million for management and chapter activities.
In 1971, contributions from all sources accounted for 78 percent of
the
national organization's total revenues of $174 million. By
1988,
contributions had tumbled to 32 percent of revenues - $315 million out
of
nearly $985 million.
That trend has caused concern. The Philadelphia chapter lists as one
of
its current management goals: "To stabilize United Way funding
relationship
while expanding supplemental fund-raising efforts."
When the Red Cross was formed in 1881, the charter spelling out
its
mission contained no references to collecting or selling blood. It
still
doesn't.
The organization began distributing blood during World War II, at
the
request of the U. S. government. The Red Cross and a group called
the
National Resource Council supplied the armed forces with 13 million
pints
throughout the war.
After the war, Red Cross officials wrestled for two years with
the
question of whether to resume collecting blood, according to two
official
histories of the organization.
In 1947, they decided to embark on a nationwide blood program to
supply
hospitals, in order to keep the Red Cross' name before the public and
to
generate new revenue, according to the histories.
"The new program marked a major departure for Red Cross - away from
the
strictures of its traditional and Charter-mandated activities and into
the
realm of civilian medical service," says a background paper written
by
Norman R. Kear, administrator of the Red Cross' blood center in
Los
Angeles.
Kear's paper lists five general purposes for the 1947 decision, one
of
which was "to develop an activity that would be constant and thus keep
the
American Red Cross continuously in the midst of the people on whom
it
depends for support."
Although it had the backing of several national groups, the Red
Cross'
initial efforts ran into opposition from other blood suppliers,
including
hospitals and community blood banks. These two groups formed the
American
Association of Blood Banks to act as a counterforce to the Red Cross.
It was not until the 1970s that the Red Cross' blood program
really
began to mushroom. From a loss of $15 million in 1971, the program
turned
in a profit of more than $9 million by 1977. And between 1980 and 1987,
the
program's operating profits never dropped below $20 million a
year,
reaching as high as $56.6 million in 1983.
The Red Cross benefited from a federal policy, developed in 1972,
that
encouraged the formation of large regional blood centers to ensure
an
adequate national blood supply.
The transformation of the Red Cross may be seen in two sets of
figures:
Between 1971 and 1987, spending on disaster relief rose from $25.5
million
to $89.4 million, an increase of 250 percent. Spending on the blood
program
went from $48 million to $488.2 million, an increase of 917 percent.
By the early 1980s, the Red Cross controlled half of all
blood
collections and was a serious competitor in the plasma business.
More
recently, the Red Cross has expanded into the growing market in bone
and
bone marrow for transplant, operating a nationwide network of bone
banks.
It is now the largest supplier in the United States of bones and tissue
for
transplant.
In the blood business, the Red Cross now accounts for slightly more
than
half the estimated 13.5 million pints of blood collected each year.
From
that blood, it makes nearly 10 million separate blood products and
sells
them to 3,300 hospitals.
For its supply, the Red Cross depends on volunteers to donate blood
each
year at thousands of businesses, churches and other sites. An estimated
4.3
million people donated blood last year.
According to Red Cross statements, the blood program is operated on
the
premise that "healthy members of the community have a responsibility
to
donate adequate amounts of blood to meet the needs of their sick
and
injured neighbors."
"Someone you love needs life-giving blood," says the Red Cross'
1988
annual report.
The Red Cross does not pay donors for their blood. In 1976, Red
Cross
president George M. Elsey wrote that paying for blood was "medically
and
morally unjustifiable.
"We of the American National Red Cross have never paid any donor at
any
time for her or his blood and most certainly never shall," Elsey wrote
to
Elmer B. Staats, then-comptroller general of the United States.
Red Cross officials also say they do not charge hospitals for the
blood
they purchase. Rather, hospitals are billed a "processing fee" that
covers
the cost of collection and production, the Red Cross says.
That distinction has worn a little thin on some operators of other
blood
banks.
"It drives me crazy when the Red Cross says it doesn't sell
blood.
That's like the supermarket saying they're only charging you for
the
carton, not the milk," said Richard D. Crowley, executive director of
the
Central Illinois Blood Bank in Springfield. "What else do you call
it?
We're in the blood-selling business."
The "processing fees" are the prices that hospitals are charged by
Red
Cross blood centers. And those prices vary dramatically from region
to
region.
In its plasma business, some Red Cross blood centers are instructed
by
national headquarters to mark up their products by fixed amounts,
known
inside the organization as "overrides." In other cases, the centers
are
free to charge hospitals whatever the local market will bear, internal
Red
Cross documents show.
And, while the Red Cross doesn't pay donors for their blood, it does
use
money as an incentive for the collection of more blood.
In 1988, the Red Cross began a pilot project in which blood centers
were
paid a $15-a-pint bonus for collecting more blood than they need - blood
to
be sold to other centers. Known as National Premium Contracts, the
bonus
program yielded an extra 26,000 pints last year, according to a Red
Cross
planning document.
The Central Blood Bank of Pittsburgh isn't the largest blood center in
the
country. Or even in Pennsylvania. The Red Cross blood center
in
Philadelphia collects about twice as much blood.
But when it comes to making money, few blood banks are in the
same
league as Pittsburgh.
For the fiscal year ended June 30, 1987, it posted an operating
profit
of $2.1 million - more than any other blood center in the
country,
according to an Inquirer study.
The Pittsburgh blood bank outperformed nearly the entire Fortune
500
when its profits were measured as a percentage of its revenues -
with a
margin of 11.9 percent. The median return on sales of all the Fortune
500
industries was just 4.6 percent that year.
Then there is the Gulf Coast Regional Blood Center in Houston.
It earned nearly $1.8 million on revenues of $15.5 million, according
to
a tax return filed in 1987 with the Internal Revenue Service. That was
the
third-highest profit earned that year by a blood bank, after Pittsburgh
and
Blood Systems Inc. of Scottsdale, Ariz., which operates blood
banks
throughout the Southwest and had a profit of $1.85 million.
As these examples show, the American Red Cross isn't the
only
organization that has earned substantial income from blood. In fact,
by
most standard business measurements, blood banks fare rather well.
The Inquirer reviewed 74 tax returns filed by 62 nonprofit blood
banks
for tax years 1986 and 1987, the most recent years for which returns
were
available. The survey included virtually every major non-Red Cross
blood
bank in the United States.
The findings:
* Twenty-four of the 62 nonprofit blood banks - 39 percent -
posted
profit margins exceeding 10 percent of their revenues, better than those
of
many large corporations.
* Seven of those blood banks had profits greater than $1 million.
* The average profit earned by blood banks was more than a half
million
dollars, with a low of $11,814 and a high of $2,117,267.
* Total profits were $27,086,414.
* More than two-thirds of the tax returns showed a profit
earned. A
total of 21 returns showed a loss for the year, with the average
loss
$231,766.
* One blood bank, the New York Blood Center, lost more than $1
million.
Nonprofit blood banks refer to their profits as "excesses
over
expenses," rather than profits. And officials are quick to point out
that
they use these funds to buy equipment or build their financial
reserves,
not to pay shareholders.
"Since those profits don't go to stockholders, they have to go back
into
programs," said Gulf Coast's president, William T. Teague. "It has
enabled
us to buy new equipment . . . and hold down our service fee (the
amount
hospitals are billed for blood). We haven't raised our fees in six or
seven
years."
Some of these profits also help pay executive salaries and perks, or
are
put in savings accounts and investments, the blood banks' tax returns
show.
For its fiscal year ended Dec. 30, 1986, Gulf Coast reported a net
worth
of $9.29 million. Nearly 63 percent of that amount - $5.84 million - was
in
savings accounts or temporary cash investments held by the blood bank.
Tax returns show that the top five officers of Gulf Coast earned a
total
of $713,358 in salaries and benefits for the year ended Dec. 31,
1986.
Teague alone received $216,153 in salary and $25,059 in benefits.
"Obviously, I think the salaries are justified. These have not been
at
the expense of the patient," Teague said. "I think a lot of people
see
nonprofit entities as poorly run programs. We do not subscribe to
that
philosophy. We didn't come to town to be mediocre."
Some administrators of nonprofit blood banks also enjoy perks that
come
with their jobs, including the use of cars, tax returns show.
Buried in the pages of items depreciated in 1986 by a blood bank
in
Jackson, Miss., for instance, is a $29,000 BMW sports sedan, purchased
by
the blood bank in July of that year.
Why did a blood bank need a BMW?
"My predecessor didn't particularly care to fly that much," said
David
Allen, director of Mississippi Blood Services Inc. "There are a number
of
meetings and conferences we need to, or are required to, attend. He felt
he
could travel to those, thereby justifying the expense."
Allen said that between July and September 1986, the
former
administrator drove the BMW round-trip from Jackson to Chicago, to
San
Antonio and to San Francisco - the latter a 4,260-mile round-trip
journey.
"The board decided after that period of time, that was an awful lot
of
traveling," Allen said.
In September 1986, the blood bank sold the BMW, replacing it
with a
$17,000 Oldsmobile Delta 88, which is used by any employee who needs it.
The three top executives of the Broward Community Blood Center
in
Lauderhill, Fla., get cars, ranging in price from $9,075 to
$13,352,
according to the blood bank's tax returns and interviews.
At Gulf Coast in Houston, Teague drives a $16,000 Ford Bronco II
leased
for him by the blood bank. Three of the center's other four top
executives
also get leased cars.
Salaries of some blood-bank administrators are equally generous.
More
than one-quarter of the administrators at 62 blood banks surveyed by
The
Inquirer earned $100,000 or more a year.
Dr. William C. Sherwood, director of the Red Cross' Penn-Jersey
Regional
Blood Services, made $135,105 in salary and benefits in fiscal year
1986,
according to a tax return for that year. He declined to say what
his
current salary is.
Salaries aren't always linked to the performance or size of the
blood
bank. Dr. Aaron Kellner, recently retired president of the New York
Blood
Center, was paid $172,500 in fiscal 1987. That year, the blood center
lost
$1,046,203.
Dr. Peter A. Tomasulo, director of the Red Cross blood program in
Miami,
was paid $166,775 in salaries and benefits in 1987. His blood bank
lost
$530,523 that year.
At Pittsburgh's Central Blood Bank, president William H.
Portman
receives a $110,000 salary and a car allowance of $500 a month.
Asked about the amount of the car allowance, Portman replied: "I'm
not
complaining. I pay taxes on that."
The Pittsburgh center, which serves 32 hospitals in two counties,
may
well be the wealthiest blood bank in the nation.
According to its tax return for the fiscal year ending June 30, 1987,
it
had a net worth of $17.7 million, of which $11.9 million was in savings
and
temporary cash investments. Portman said he was building financial
reserves
to build a foundation for blood research.
Portman said that in addition to selling blood to hospitals,
the
Pittsburgh blood bank has an active laboratory testing business
and
operates the transfusion services for three hospitals.
"Quite frankly, those services are profitable," Portman said.
According to its tax return, the blood bank rendered 147,975
laboratory
and outpatient services in 1986, worth $3.89 million.
Portman said it makes sense for his blood bank to perform tests for
the
hospitals because it can handle a larger volume and save the
hospitals
money. And the blood bank diversifies its operation.
"I think it's finding those niches in the market that make
sense,"
Portman said. "We have a lot of services that other blood centers
don't
offer."
PHOTO (1), 1. Kellner, whose blood center lost money in 1987,
earned
$172,500 that year. (Special to The Inquirer / PETER MORGAN)
Some Red Cross blood centers also offer cash bonuses to workers
who
solicit blood donors by telephone. The workers earn the bonuses,
tacked
onto their salaries, by exceeding goals set by the blood centers.
Telephone solicitors for the Red Cross blood program in Philadelphia
can
earn bonuses of $80 to $200 a year by exceeding recruitment goals.
To earn a $200 bonus, a solicitor must average three donor
appointments
per hour during the year, according to spokeswoman Christie
Phillips.
Recruiters are required to make at least 1.75 donor appointments an
hour,
Phillips said.
Supervisors also are eligible for bonuses - up to $600 a year - based
on
the performance of the recruiters they oversee, Phillips said.
Barker said the practice of offering financial incentives
to
tele-recruiters was consistent with the volunteer philosophy the Red
Cross
always has espoused.
"We draw a very clear line between paying donors and paying fees .
. .
whether they are a cost-plus incentive or whatever. We see those as
totally
different issues. At least I do."
*
In the last 18 months, problems in the Red Cross' blood program
have
shaken the organization and had a severe impact on finances.
Nearly two-thirds of the 56 regional blood centers were identified
as
having deficiencies following the discovery in March 1988 of problems
at
blood centers in Washington and Nashville.
Most of the safety problems involved inadequate testing of blood
before
it was released or failures involving the computerized records systems
used
to log results of blood tests and to keep track of dangerous donors.
Between March 1988 and March 1989, the Red Cross recalled 5,700 units
of
blood and blood components that had not been properly tested for AIDS
and
hepatitis. (The Philadelphia blood bank was not among those with
safety
problems.) And the Red Cross had to shut down its $75 million-a-year
plasma
business for six months because of concerns about blood safety.
In late February, the Red Cross' board of directors named a
special
committee to examine the operation of its blood program. The committee
was
expected to report its findings in October.
The problems led to a shakeup of top management at national
headquarters
in Washington and in the field. President Richard F. Schubert and
three
other senior staff members, including the head of computer
operations,
announced their resignations in April. Several top administrators
of
regional blood centers were demoted or replaced, and top
blood-program
staff at national headquarters has been reorganized.
A Red Cross internal investigation and FDA inspection reports traced
the
release of some suspect blood to vaguely worded instructions from
national
headquarters on testing for AIDS - with different blood
centers
interpreting the test instructions in various ways.
"This was the single biggest cause of erroneous releases (of
suspect
blood). . . . Thus our own (directives) were the principal cause of
our
current plasma financial crisis and the attendant media attention
about
erroneous releases," the November 1988 internal report said.
Another internal report was highly critical of the computerized
system
for recording results of AIDS and other tests on blood and for
keeping
track of dangerous donors.
"Efforts in automation are dismal failures; poor system design
has
contributed to (the) erroneous release problem; FDA and
independent
consultants indicate that systems do not comply with
(federal)
requirements," the report said.
The problems also affected morale and exacerbated tensions between
the
regional blood centers and national Red Cross officials at headquarters
in
Washington. The relationship between national headquarters and the
regions
was characterized as one of "intensely mutual lack of trust" in a Dec.
7,
1988, analysis prepared by directors of a number of regional blood
centers.
"NHQ staff are not accountable. . . . Lack of stable knowledgeable
staff. . . . Organization is slow to change in a rapidly changing
environment . . . and is inwardly focused. . . . Too much time spent
doing
business within the organization," were some of the criticisms made in
the
analysis.
In a national teleconference in February to introduce members of
the
newly appointed study commission and to calm employees' concerns,
Schubert,
then president, noted that the Red Cross was suffering from
"unfortunate
divisiveness and hostility."
Dr. Fred Katz, a vice president of the Red Cross, said during
the
teleconference that the safety problems had resulted "in
decreased
confidence in our ability to release only safe products. The public and
our
customers had opportunity to question our claims of safety." And because
of
the quarantine of Red Cross plasma, and of the cost of dealing with
the
safety problems, "Red Cross was financially damaged," Katz said.
"We have just got to operate in such a way . . . we don't
have a
repetition of what has happened over this last year," Schubert said
during
the two-hour teleconference. The Inquirer obtained a videotape of
the
meeting.
As a result of the shutdown of the plasma program and other
problems,
operating profits for fiscal year 1988 dropped to about $4 million
from
nearly $34 million the previous year. The Red Cross borrowed $20.7
million
from the blood program's reserves of $209 million for capital
improvements.
Barker said that most of the problems were compliance issues, which
did
not directly affect public safety.
Since January, the FDA has released most of the quarantined
plasma
medicines and Red Cross officials have launched a wide-ranging offensive
to
get their $75 million plasma program back on track. Regional blood
centers
have been instructed by national headquarters to collect as much plasma
as
possible, internal documents show.
"Red Cross ability to maintain or increase our market share . . . is
a
key organizational goal," a Feb. 17 budget-planning document states.
It
also noted that the Red Cross anticipated recovering a
"substantial
increase" in revenues from the blood-clotting medicine it sells
to
hospitals and hemophiliacs.
In another step aimed at shoring up the Red Cross' overall
financial
position, chairman George Moody late last year informed 5,700 retirees
of
the board of governors' plans to terminate the Red Cross' $730
million
pension plan and to replace it with a different system.
Contending that the pension plan was overfunded, the board proposed
to
tap $100 million of an estimated $400 million surplus for
operating
expenses.
The plan angered many Red Cross retirees. Moody defended the action
in a
letter to one retiree who had objected. As a nonprofit organization,
he
wrote, "we believe that a portion of the excess funds . . . should be
used
to meet humanitarian and organizational needs."
In an interview, pensioner James B. Foley described the plan
as a
"ripoff" and said that the average Red Cross pensioner receives a
monthly
check of $422 - about $5,000 a year.
Virginia Mankin, manager and secretary of the retirement fund, said
the
number of pensioners receiving benefits as of July 26 was 5,757.
The
average monthly check was $436 - or $5,232 a year.
She said that pensions are based on the number of years a person
worked
at Red Cross - the more years, the higher the pension. "There's quite a
few
people who would leave at age 65 with very low service," she said. "It
also
covers part-time and per diem people."
As the blood portion of its operations has grown, officials of the
Red
Cross in Washington have become increasingly secretive, apparently
for
competitive reasons, regional Red Cross managers and others say.
The organization used to publish annually a report on its
operations
that contained information about each of its 56 blood centers, with
data
ranging from amount of blood collected to prices charged.
"Now you practically have to go underground to get one," said Nancy
R.
Holland, former executive director of the American Blood Commission,
an
organization that once helped shape public policies on blood.
Many reports containing routine data on Red Cross operations are
now
stamped "confidential," "secret" or "For Internal Use Only." Key
officials
within the Red Cross' regional blood banks are required to
sign
confidentiality statements, promising not to disclose financial
and
operational data.
Most Red Cross officials are truly interested in doing a good job,
Kear
said. But he said the organization has become "unnecessarily
bureaucratic"
and "paranoid."
Others use even stronger language.
"They actually have a mind-set that on the day of creation, when the
Earth was just one big steaming molten mass and hot sulfur clouds were
churning around, the hand of God reached through with a bag of blood and
handed it to them and said, 'Here, take this exclusively and spread
it
among
all mankind,' " said Thomas M. Asher, chairman of a publicly traded
company
in Sherman Oaks, Calif., that competes with the Red Cross.
"The Red Cross in my mind is the evil empire," said Leslie
Vogt,
president of a nonprofit blood bank in Richmond, Va., that is
not
affiliated with the Red Cross. "They want to be the only blood
supplier
nationally. It's run like a big business. And it's more political than
most
people think."
For nearly a decade, between 1977 and 1987, the Richmond center
bought
several thousand pints of blood a year from the Red Cross' regional
blood
program in Roanoke, 165 miles away. Vogt needed the blood to
cover
shortages in her city.
"It was a good, friendly relationship. They had a surplus of blood
and
we needed blood," Vogt said.
Then, in 1986, she was told by Roanoke officials that she would have
to
buy blood through the Red Cross' new national clearinghouse. That
meant
paying more for the blood and Vogt said she was afraid Richmond would
be
cut off if there was a shortage in the Red Cross system somewhere.
"They took a relationship that worked for 10 years and wrecked it,"
Vogt
said.
Vogt opted to buy her blood from several other blood banks.
"It's crazy. You have two blood banks 165 miles apart that can't
share
blood, while the blood drawn in Roanoke is probably being shipped all
over
the country," Vogt said.
Not for commercial use. Solely to be used for the educational purposes of research and open discussion.
Poor multimillionare Tom Hecht crying the blues about the red cross making money. It was his company that sat on the Arkansas tainted blood recall for two months while this stuff was injected into innocent hemophiliacs! Uuggggg!
Notice that the Hecht quote is the only thing I chose to highlight in this piece.
Gaul is galled by profits. It ain't the profits; it's the homicides, stupid.
No offense intended to Gilbert M. Gaul, who won The Philadelphia Inquirer a 1990 Pulitzer for this five part series and previously won a Pulitzer for his local reporting in 1979. I trust it is obvious that I was adapting James Carville's colorful phrase to make a point T'wit has repeatedly made on this forum.
Now Hecht can use his millions to hire a legion of lawyers to fight off any claims of wrong doing. I feel libel chill in the air!
Great series, Wallaby! Thank you! If the Red Cross is a business, then it should be responsible for its actions!
That's a lot of profits, they could have heat treated all their blood, and still come out with a healthy bottom line,
helping people, is just their way of making money, I have no doubt that the situation is the same in Canada....on a smaller scale.
The red cross doesn't surprise me, years ago, there was a bad flood somewhere in this country, lots of volunteers worked very hard to help out, the salvation army and the red cross were there to supply food and water for the volunteers, the salvation army supplied everything for free,
the red cross charged the going rate.
, the Red Cross' main business is no longer disaster relief.
Its main business is selling blood.
Thank God our own Liddy Dole had the wherewithal to step up and ASK to overhaul this system in 1991 (as she began her first "volunteer" year as Red Cross maven).
Wallaby's a treasure. Plain and simple.
Is this (series) the #'s 344, 345, 346, 347 and 348 from my little page 2?
Yeppy Budge. I just checked. It's funny how I can skim over an article and it doesn't ring a bell, until something happens and then I link things together. I suppose it works the same for all. It's such a convoluted web of corruption. Thanks for all the work and records you keep.
Disclaimer: Opinions posted on Free Republic are those of the individual
posters and do not necessarily represent the opinion of Free Republic or its
management. All materials posted herein are protected by copyright law and the
exemption for fair use of copyrighted works.
[
Top
|
Latest Posts
|
Latest Articles
|
Self Search
|
Add Bookmark
|
Post
|
Abuse
|
Help!
]
Red Cross officials hope to collect up to 104,000 extra pints
annually,
according to the document. At $15 a pint, that would mean a payout
of
$1,560,000 in bonuses to blood banks.
"There is a genuine fear of outsiders, which is unfortunate because
it
makes it appear we have something to hide," said Kear, administrator of
the
Red Cross blood center in Los Angeles.
PHOTO (1), 1. Seeking to collect extra blood to be sold, some Red
Cross
centers offer bonuses to solicitors who exceed recruitment goals.
(The
Philadelphia Inquirer / REBECCA BARGER), CHART (2), 1. Revenues
and
expenses, 1988 (SOURCE: American Red Cross; The Philadelphia
Inquirer /
KIRK MONTGOMERY), 2. Spending on blood vs. disaster relief (SOURCE:
Red
Cross, tax returns, financial statements; The Philadelphia Inquirer)
[
Reply | Top | Last ]
To: Wallaby
[
Reply | To 1 | Top | Last ]
To: BigM
[
Reply | To 2 | Top | Last ]
To: BigM
[
Reply | To 2 | Top | Last ]
To: Gilbert M. Gaul
[
Reply | To 4 | Top | Last ]
To: Wallaby
[
Reply | To 4 | Top | Last ]
To: Wallaby
[
Reply | To 5 | Top | Last ]
To: Wallaby
[
Reply | To 1 | Top | Last ]
To: The Red Cross' main business is SELLING BLOOD.
[
Reply |
Private Reply | To 3 | Top | Last ]
To: Deb
[
Reply |
Private Reply | To 1 | Top | Last ]
To: the Red Cross' main business is no longer disaster relief. It's main business is selling blood.
[
Reply |
Private Reply | To 10 | Top | Last ]
To: Bloodhounds, Askel5, Wallaby, BigM, Budge
[
Reply |
Private Reply | To 11 | Top | Last ]
To: adanaC
[
Reply |
Private Reply | To 12 | Top | Last ]
To: adanaC
[
Reply |
Private Reply | To 12 | Top | Last ]
To: Budge
[
Reply |
Private Reply | To 14 | Top | Last ]
FreeRepublic
, LLC, PO BOX 9771, FRESNO, CA 93794
Forum Version 2.0a Copyright © 1999 Free Republic, LLC